|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7120 USD | +3.94% |
|
+1.71% | -47.26% |
| 07-01 | CbdMD Launches Oasis Mixer, A Hemp-Derived Zero-Proof THC Spirit | CI |
| 06-16 | CbdMD, Inc. Appoints Wade Brown as Chief Marketing Officer | CI |
| Market Cap | 7.47M 6.55M 6.03M 5.6M 10.63M 713M 10.77M 72.17M 28.09M 350M 28.07M 27.45M 1.21B | P/E 2026 * |
-3.75x | P/E 2027 * | -10.2x |
|---|---|---|---|---|---|
| Enterprise Value | 7.47M 6.55M 6.03M 5.6M 10.63M 713M 10.77M 72.17M 28.09M 350M 28.07M 27.45M 1.21B | EV / Sales 2026 * |
0.34x | EV / Sales 2027 * | 0.32x |
| Free-Float |
89.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: cbdMD, Inc.
| 1 day | +3.94% | ||
| 1 week | +1.71% | ||
| Current month | +5.79% | ||
| 1 month | -1.59% | ||
| 3 months | -2.48% | ||
| 6 months | -38.09% | ||
| Current year | -47.26% |
| 1 week | 0.66 |  | 0.71 |
| 1 month | 0.65 | | 0.74 |
| Current year | 0.63 | | 1.34 |
| 1 year | 0.47 | | 2.56 |
| 3 years | 0.47 | | 13.84 |
| 5 years | 0.47 | | 1,087.2 |
| 10 years | 0.47 | | 2,606.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
T. Kennedy
CEO | Chief Executive Officer | 47 | 01/03/2023 |
Zeb Booker
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2019 |
Sibyl Swift
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Bakari Sellers
BRD | Director/Board Member | 41 | 01/03/2017 |
William Raines
BRD | Director/Board Member | 66 | 19/04/2019 |
Scott Stephen
CHM | Chairman | 60 | 03/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-14 | Free | Chairman | 1,572 | 0.0150% | ||
| 04-14 | Free | Director | 1,572 | 0.0150% | ||
| 04-14 | Free | Director | 1,572 | 0.0150% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.94% | +1.71% | -17.21% | -93.82% | 7.47M | |
| -1.14% | -2.43% | +53.72% | +159.07% | 1,070B | |
| -1.41% | +0.32% | +66.23% | +60.48% | 624B | |
| -2.42% | +0.18% | +34.59% | +85.62% | 450B | |
| -0.51% | +0.53% | +31.00% | +25.82% | 328B | |
| +2.13% | +1.91% | +40.63% | +42.14% | 292B | |
| +1.06% | -0.28% | +29.31% | +48.65% | 284B | |
| +2.32% | +4.37% | -25.58% | -38.85% | 217B | |
| -2.06% | +1.63% | +22.87% | +64.34% | 198B | |
| -1.26% | +2.60% | +15.98% | +70.00% | 161B | |
| Average | +1.34% | +1.14% | +25.15% | +42.34% | 362.44B | |
| Weighted average by Cap. | +1.31% | +0.77% | +40.37% | +81.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.15M 19.4M 17.87M 16.59M 31.5M 2.11B 31.92M 214M 83.25M 1.04B 83.19M 81.37M 3.6B | 23.26M 20.37M 18.76M 17.42M 33.07M 2.22B 33.52M 225M 87.41M 1.09B 87.35M 85.44M 3.78B |
| Net income | -1.9M -1.67M -1.53M -1.42M -2.7M -181M -2.74M -18.37M -7.15M -89.06M -7.14M -6.99M -309M | -902K -790K -728K -675K -1.28M -86.04M -1.3M -8.71M -3.39M -42.23M -3.39M -3.31M -146M |
| Net Debt | - | - |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | $0.7120 | +3.94% | 87,118 |
| 02/07/26 | $0.6850 | +0.75% | 72,420 |
| 01/07/26 | $0.6799 | +1.03% | 106,658 |
| 30/06/26 | $0.6730 | -3.86% | 122,972 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7120USD
Average target price
2.000USD
Spread / Average Target
+180.90%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YCBD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
